Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020785 · ClinicalTrials.gov registry record · NA
Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02020785 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 31 participants.
The verdict
NCT02020785, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Phosphorus-based food additives are commonly used by food manufacturers for many applications, such as enhancing flavor, in ready-to-eat foods and beverages. While these additives can significantly increase an individual's daily phosphorus intake, little is known about the effect of dietary phosphorus on kidney health. In this study, the investigators will first lower baseline phosphorus intake to about 1000mg/d by educating participants to avoid foods with phosphorus additives. Then, participants will be randomized to a higher phosphorus period (\~2gm/d) and a lower phosphorus period (\~1gm/d) by providing unaltered, commercially-available food/beverage products with and without phosphorus additives. The investigators hypothesize that participants will have higher urine albumin excretion and fibroblast growth factor-23 (FGF-23) during the higher phosphorus period compared to the lower phosphorus period.
Interventions
- OTHER Higher phosphorus period
- OTHER Lower phosphorus period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02020785
The ClinicalTrials.gov registry entry for NCT02020785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Higher phosphorus period is the first listed.
NCT02020785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02020785 about?
NCT02020785 is a clinical study titled "Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23". Phosphorus-based food additives are commonly used by food manufacturers for many applications, such as enhancing flavor, in ready-to-eat foods and beverages. While these additives can significantly increase an individual's daily phosphorus intake, little is known about the effect of dietary phosphor...
What is the current status of trial NCT02020785?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2014-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02020785?
The interventions under investigation include: Higher phosphorus period (OTHER), Lower phosphorus period (OTHER).
Who is sponsoring clinical trial NCT02020785?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.